Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ultomiris (ravulizumab-cwvz)
Biotech
Novartis touts new budding disease med as it battles AstraZeneca
Novartis is touting expanded data of its phase 3-stage rare disease med as it takes on a couple of AstraZeneca gems.
Max Bayer
Dec 13, 2022 10:00am
Novartis takes another swipe at AstraZeneca's rare disease gems
Dec 8, 2022 10:28am
AstraZeneca's danicopan improves hemoglobin levels in phase 3
Sep 16, 2022 9:40am
